Gary L. Corona is a seasoned finance executive with over three decades of experience in corporate finance, strategic planning, and leadership within the healthcare and technology sectors. He began his career at a prominent accounting firm, where he honed his expertise in financial auditing and compliance, earning his CPA certification early on. Corona later transitioned to the corporate world, holding progressively senior roles at companies like General Electric and Boston Scientific, where he specialized in mergers and acquisitions, capital allocation, and risk management. His educational foundation includes a Bachelor's degree in Accounting from the University of Minnesota and an MBA from Harvard Business School, which equipped him with a robust analytical mindset and global business acumen. At Medtronic PLC, Corona served as Senior Vice President of Corporate Finance, where he played a pivotal role in overseeing the company's global financial operations, including treasury, tax, and investor relations. During his tenure, he led initiatives that streamlined financial reporting processes, resulting in enhanced efficiency and cost savings exceeding $100 million annually. As Interim Chief Financial Officer, Corona stepped in during a critical transition period, guiding the company through complex regulatory challenges and a major acquisition that expanded Medtronic's portfolio in minimally invasive therapies. His strategic foresight contributed to record-breaking revenue growth and strengthened the company's position as a leader in medical technology innovation. Beyond his professional achievements, Corona is recognized for mentoring emerging finance leaders and advocating for ethical financial practices in the industry. He has served on several advisory boards and contributed to publications on corporate governance. Although he has since retired from his executive roles at Medtronic, Corona continues to influence the field through consulting and speaking engagements, leaving a lasting legacy of fiscal discipline and innovation in healthcare finance.